Immunohistochemically, parafibromin expression was employed as an independent factor for a better overall or relapse-free survival of the patients with colorectal cancer [15] or head and neck squamous cell carcinoma [18] respectively. This evidence concerns the gene CDC73 and colorectal cancer.